ErbB4 Is a Potential Key Regulator of the Pathways Activated by NTRK-Fusions in Thyroid Cancer › Research Explorer

DOI

https://doi.org/10.3390/app12052506
Final published version

Andrey Kechin
Viktoriya Borobova
Alexander Kel
Anatoliy Ivanov
Maxim Filipenko

Original language	English
Article number	2506
Journal	Applied Sciences (Switzerland)
Volume	12
Issue number	5
DOIs	https://doi.org/10.3390/app12052506
Publication status	Published - 1 Mar 2022

Research areas

ErbB4, Gene fusions, NTRK, Pathways, Thyroid cancer

OECD FOS+WOS

2.05 MATERIALS ENGINEERING
2.04 CHEMICAL ENGINEERING
1.03 PHYSICAL SCIENCES AND ASTRONOMY

ID: 35636181